InsidersTradesSigma
Pharming Group N.V. Stock: price and management transactions · Netherlands · AFM
Follow the Pharming Group N.V. stock price and the full insider trade history of the company, a publicly traded company based in Netherlands. Shares are listed on NL NL, under the authority of AFM. Operating in the Healthcare & Pharma sector, Pharming Group N.V. has recorded 122 insider filings. Market capitalisation: €869m. The latest transaction was reported on 28 May 2026 (Purchase). Among the most active insiders: S. de Vries. Every trade is openly available.
122
Insider Decl.
0
Thresholds
€88m
111 ops.
Buy Volume
€398,700
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharming Group N.V. Strong Buy (bullish), based on 3 analysts. Average price target: €2.38.
27Σ signal
Fundamental score
Ranked 16,304 of 25,973 companies
43.9
score / 100
Value38
Quality50
FCF yld6.1%
Earn yld0.3%
EV/EBITDA28.8x
ROE5.0%
Gross mgn88%
Net mgn0.8%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 May 2026
Declarations122 total
38,583 shares0Gewoon aandeelAFM:194920
Ideal exit: 22 Feb 2027 (T+270)
38,583 shares0Gewoon aandeelAFM:194921
Ideal exit: 22 Feb 2027 (T+270)
38,583 shares0Gewoon aandeelAFM:194923
Ideal exit: 22 Feb 2027 (T+270)
2,091,330 shares0Restricted shareAFM:189920
Ideal exit: 7 Dec 2026 (T+270)
-255,825 shares0Restricted shareAFM:187617
3,613 shares0Gewoon aandeelAFM:183064
Ideal exit: 3 Aug 2026 (T+270)
17,550 shares0Gewoon aandeelAFM:176307
Ideal exit: 8 Mar 2026 (T+270)
31,400 shares0Gewoon aandeelAFM:176243
Ideal exit: 7 Mar 2026 (T+270)
31,400 shares0Gewoon aandeelAFM:176244
Ideal exit: 7 Mar 2026 (T+270)
3,614,572 shares0Restricted shareAFM:171687
Ideal exit: 7 Dec 2025 (T+270)
1,023,302 shares0Restricted shareAFM:171449
Ideal exit: 2 Dec 2025 (T+270)
8,487 shares0Gewoon aandeelAFM:165350
Ideal exit: 28 Jul 2025 (T+270)
8,487 shares0Gewoon aandeelAFM:165349
Ideal exit: 28 Jul 2025 (T+270)
8,487 shares0Gewoon aandeelAFM:161829
Ideal exit: 28 Apr 2025 (T+270)
25 of 122 declarations
About Pharming Group N.V.
Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the Amsterdam Stock Exchange (XAMS).
